Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis

W, Guan; W, Liang; Y, Zhao; H, Liang; Z, Chen; Y, Li; X, Liu; R, Chen; C, Tang; T, Wang; C, Ou; L, Li; P, Chen; L, Sang; W, Wang; J, Li; C, Li; L, Ou; B, Cheng; S, Xiong; Z, Ni; J, Xiang; Y, Hu; L, Liu; H, Shan; C, Lei; Y, Peng; L, Wei; Y, Liu; Y, Hu; P, Peng; J, Wang; J, Liu; Z, Chen; G, Li; Z, Zheng; S, Qiu; J, Luo; C, Ye; S, Zhu; L, Cheng; F, Ye; S, Li; J, Zheng; N, Zhang; N, Zhong; J, He

doi:10.1101/2020.02.25.20027664

Public

Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis

Shared by NobleBlocks on Feb 27, 2020 • 12:00 AM UTC

Authors:

Guan W

Liang W

Zhao Y

Abstract

Objective To evaluate the spectrum of comorbidities and its impact on the clinical outcome in patients with coronavirus disease 2019 (COVID-19). Design Retrospective case studies Setting 575 hospitals in 31 province/autonomous regions/provincial municipalities across China Participants 1,590 laborat...

Discussions